William Blair Investment Management LLC purchased a new stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 436,996 shares of the company's stock, valued at approximately $30,013,000. William Blair Investment Management LLC owned 2.93% of U.S. Physical Therapy at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Hantz Financial Services Inc. grew its stake in U.S. Physical Therapy by 56.4% during the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company's stock valued at $29,000 after acquiring an additional 132 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at about $30,000. Advisory Services Network LLC purchased a new stake in shares of U.S. Physical Therapy in the third quarter worth approximately $39,000. iSAM Funds UK Ltd purchased a new stake in shares of U.S. Physical Therapy in the third quarter worth approximately $52,000. Finally, Parallel Advisors LLC boosted its holdings in shares of U.S. Physical Therapy by 75.2% during the first quarter. Parallel Advisors LLC now owns 785 shares of the company's stock worth $59,000 after purchasing an additional 337 shares during the period.
Insider Activity
In other U.S. Physical Therapy news, Director Peter Francis Minan acquired 492 shares of the firm's stock in a transaction that occurred on Monday, June 8th. The stock was purchased at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the acquisition, the director owned 2,923 shares of the company's stock, valued at approximately $184,558.22. This trade represents a 20.24% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 2.40% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts recently commented on USPH shares. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Zacks Research raised shares of U.S. Physical Therapy from a "strong sell" rating to a "hold" rating in a research note on Wednesday, May 27th. Barrington Research boosted their price target on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Citizens Jmp restated a "market outperform" rating and set a $98.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Finally, Citigroup reaffirmed a "market outperform" rating on shares of U.S. Physical Therapy in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $99.50.
View Our Latest Analysis on USPH
U.S. Physical Therapy Trading Up 0.2%
Shares of NYSE USPH opened at $78.16 on Friday. The business has a 50 day simple moving average of $73.59 and a 200 day simple moving average of $73.90. U.S. Physical Therapy, Inc. has a 52 week low of $58.19 and a 52 week high of $93.50. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of 459.79, a PEG ratio of 2.15 and a beta of 1.13. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.27 and a current ratio of 1.27.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.75 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.81 by ($0.06). The business had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. U.S. Physical Therapy's revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.81 earnings per share. On average, research analysts predict that U.S. Physical Therapy, Inc. will post 2.95 earnings per share for the current fiscal year.
U.S. Physical Therapy Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 21st will be issued a dividend of $0.46 per share. The ex-dividend date is Friday, August 21st. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.4%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 1,082.35%.
U.S. Physical Therapy Profile
(
Free Report)
U.S. Physical Therapy, Inc NYSE: USPH is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.